Skip to main content

Table 2 Final Cox Proportional Hazards regression model for CMV incidence (with mTOR inhibitor fitted as a time dependent variable)

From: Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience

Variable

Adjusted Hazard Ratio (95% CI)

p-value

Recipient aged ≥65 at transplant

1.85 (0.96, 3.58)

0.067

Donor aged ≥60

2.24 (1.36, 3.67)

0.001

Deceased donor

2.03 (1.18, 3.50)

0.011

Donor/Recipient CMV status

 D−/R+ (reference)

−

−

 D+/R−

5.44 (2.49, 11.89)

<0.001

 D+/R+

1.73 (0.84, 3.56)

0.138

mTOR inhibitor

0.31 (0.09, 1.02)

0.054